UK markets closed

NuGene International, Inc. (NUGN)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0107+0.0009 (+9.18%)
At close: 03:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.70M
Enterprise value 8.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.34
Price/book (mrq)0.20
Enterprise value/revenue 23.91
Enterprise value/EBITDA -1.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-72.50%
S&P500 52-week change 326.27%
52-week high 30.0650
52-week low 30.0040
50-day moving average 30.0102
200-day moving average 30.0125

Share statistics

Avg vol (3-month) 3447.71k
Avg vol (10-day) 3330.82k
Shares outstanding 5812.8M
Implied shares outstanding 6812.8M
Float 8800.22M
% held by insiders 14.66%
% held by institutions 10.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -191.85%
Operating margin (ttm)-182.55%

Management effectiveness

Return on assets (ttm)-8.13%
Return on equity (ttm)-11.00%

Income statement

Revenue (ttm)1.82M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-37.60%
Gross profit (ttm)N/A
EBITDA -2.66M
Net income avi to common (ttm)-3.49M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.05k
Total cash per share (mrq)0
Total debt (mrq)26.38k
Total debt/equity (mrq)0.06%
Current ratio (mrq)4.56
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-264.43k
Levered free cash flow (ttm)-4.32M